OPTIONS AND WARRANTS (Details 1) - Equity Option [Member] |
6 Months Ended |
|---|---|
|
Jun. 30, 2025
USD ($)
$ / shares
shares
| |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Number of Options, Beginning | shares | 611,214 |
| Weighted-Average Exercise Price, Beginning | $ 1.00 |
| Weighted-Average Remaining Contractual Term, Beginning | 8 years 9 months |
| Weighted-Average Grant Date Fair Value, Beginning | $ 0.004 |
| Aggregate Intrinsic Value, Beginning | $ | $ 2,750 |
| Number of Options, Issued | shares | |
| Weighted-Average Exercise Price | |
| Weighted-Average Grant Date Fair Value | |
| Aggregate Intrinsic Value | $ | |
| Number of Options, Ending | shares | 611,214 |
| Weighted-Average Exercise Price, Ending | $ 1.00 |
| Weighted-Average Remaining Contractual Term, Ending | 8 years 3 months |
| Weighted-Average Grant Date Fair Value, Ending | $ 0.004 |
| Aggregate Intrinsic Value, Ending | $ | $ (610,694) |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The addition or reduction in the number of reserved shares that could potentially be issued under the option plan attributable to reasons other than grants, exercises, forfeitures, and expirations during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
| X | ||||||||||
- Details
|